| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/18/2009 | US20090155363 Methods for oral administration of active drugs |
| 06/18/2009 | US20090155362 Method of cross-linking hyaluronic acid with divinulsulfone |
| 06/18/2009 | US20090155361 Tablet with multiple drug-containing sections |
| 06/18/2009 | US20090155360 Orally disintegrating tablets comprising diphenhydramine |
| 06/18/2009 | US20090155359 Granulated particles, tablets and method for producing granulated particles |
| 06/18/2009 | US20090155358 Pharmaceutical compositions of short-acting hypnotic agents in modified-release forms and the procedures to prepare the mentioned formulation |
| 06/18/2009 | US20090155357 Alcohol Resistant Pharmaceutical Formulations |
| 06/18/2009 | US20090155356 Thixotropic oil based vehicle for pharmaceutical compositions |
| 06/18/2009 | US20090155355 Particles in a capsule |
| 06/18/2009 | US20090155354 Dispensing encapsulated liquids into body cavities |
| 06/18/2009 | US20090155353 Microemulsions for pharmaceutical compositions |
| 06/18/2009 | US20090155352 Microemulsion containing indolocarbazole compound and dosage forms containing the same |
| 06/18/2009 | US20090155351 Solid Vaccine Formulation |
| 06/18/2009 | US20090155350 Chlamydia antigens and protein vaccine |
| 06/18/2009 | US20090155349 Methods of treating influenza viral infections |
| 06/18/2009 | US20090155348 Detoxified Recombinant Botulinum Neurotoxin |
| 06/18/2009 | US20090155347 Cosmetic Composition for Stimulating the Synthesis of Proteins of the Basement Membrane |
| 06/18/2009 | US20090155346 Preparation of powders containing colloidal particles |
| 06/18/2009 | US20090155345 Methods for affecting liposome composition ultrasound irradiation |
| 06/18/2009 | US20090155344 Preparation and application of biodegradable-material-made microsphere vascular embolus containing liposome-encapsulated cytokines |
| 06/18/2009 | US20090155343 Tamsulosin-Containing Transdermal Patch |
| 06/18/2009 | US20090155342 Mineral technologies (MT) for acute hemostasis and for the treatment of acute wounds and chronic ulcers |
| 06/18/2009 | US20090155340 Method of cell storage in a delivery system |
| 06/18/2009 | US20090155339 Biocompatible Antimicrobial Filament Material |
| 06/18/2009 | US20090155338 Chronotherapeutic Ocular Delivery System Comprising a Combination of Prostaglandin and a Beta-Blocker for Treating Primary Glaucoma |
| 06/18/2009 | US20090155336 Neuromodulatory methods for treating pulmonary disorders |
| 06/18/2009 | US20090155331 Injectable nanoparticulate olanzapine formulations |
| 06/18/2009 | US20090155326 Layered drug delivery polymer monofilament fibers |
| 06/18/2009 | US20090155320 Method for producing hydroxyapatite particles |
| 06/18/2009 | US20090155319 Method for producing cosmetic and/or dermatological powder |
| 06/18/2009 | US20090155315 Pharmaceutical product |
| 06/18/2009 | US20090155313 Vaccine Against Salmonid Rickettsial Septicaemia Based on Arthrobacter Cells |
| 06/18/2009 | US20090155309 Novel vaccine |
| 06/18/2009 | US20090155307 Immunostimulatory nucleic acid oil-in-water formulations and related methods of use |
| 06/18/2009 | US20090155283 Noncompetitive Domain Antibody Formats That Bind Interleukin 1 Receptor Type 1 |
| 06/18/2009 | US20090155272 Targeted pharmaceuticals and ligands |
| 06/18/2009 | US20090155235 Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 06/18/2009 | US20090155189 Preparations, Methods and Kits Useful for the Treatment of Cough |
| 06/18/2009 | US20090155187 Drug for inhibiting vascular intimal hyperplasia |
| 06/18/2009 | US20090155186 Compositions and methods for treating inflammatory conditions |
| 06/18/2009 | US20090155185 Medicaments for inhalation comprising an anticholinergic and a betamimetic |
| 06/18/2009 | US20090155178 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/18/2009 | US20090155176 Compositions and methods for treatment of diabetic retinopathy |
| 06/18/2009 | US20090155174 RNA Interference Mediating Small RNA Molecules |
| 06/18/2009 | DE202009003549U1 Variabel und präzise dosierbare feste Arzneiform enthaltend ein Antiepileptikum Variable and precisely metered solid dosage form comprising an antiepileptic drug |
| 06/18/2009 | DE102007059752A1 Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone Functionalized solid polymer nanoparticles comprising epothilones |
| 06/18/2009 | CA2709208A1 Phenylephrine pharmaceutical formulations and compositions for transmucosal absorption |
| 06/18/2009 | CA2708832A1 O-desmethyl-venlafaxine for treating major depressive disorder |
| 06/18/2009 | CA2708762A1 Formulation of insulinotropic peptide conjugates |
| 06/18/2009 | CA2708615A1 Collagen-based matrices with stem cells |
| 06/18/2009 | CA2708234A1 Aqueous loxoprofen-containing patches |
| 06/18/2009 | CA2708233A1 Tape preparation comprising etodolac in ionic liquid form |
| 06/18/2009 | CA2708159A1 Pharmaceutical formulation comprising ezetimibe |
| 06/18/2009 | CA2708152A1 Orally disintegrating tablets comprising diphenhydramine |
| 06/18/2009 | CA2708146A1 Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 06/18/2009 | CA2708145A1 Compositions for inducing immune responses |
| 06/18/2009 | CA2708137A1 Use |
| 06/18/2009 | CA2708083A1 Organic compounds |
| 06/18/2009 | CA2707969A1 Micronized opioid compositions, formulations and dosage forms and methods of making same |
| 06/18/2009 | CA2707594A1 Organic compounds |
| 06/18/2009 | CA2707282A1 Salts of active ingredients with polymeric counterions |
| 06/18/2009 | CA2706658A1 Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition |
| 06/18/2009 | CA2704079A1 Multi-zone films |
| 06/17/2009 | EP2070551A1 Improved thickened beverages for dysphagia |
| 06/17/2009 | EP2070550A1 Use of combinations comprising a corticosteroid and a pyrimidopyrimidine in the treatment of inflammatory diseases |
| 06/17/2009 | EP2070539A1 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as medicine |
| 06/17/2009 | EP2070538A1 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic |
| 06/17/2009 | EP2070533A1 Use of a compound derived from P-hydroxyphenyl propionic acid for the treatment of psoriasis |
| 06/17/2009 | EP2070532A1 O/w/o emulsion containing lignan compound, and composition comprising the same |
| 06/17/2009 | EP2070521A1 Surface-modified nanoparticles |
| 06/17/2009 | EP2070520A1 Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media |
| 06/17/2009 | EP2070519A1 Preparation for the prevention and/or treatment of dementia syndromes |
| 06/17/2009 | EP2070518A2 Ophthalmic solutions |
| 06/17/2009 | EP2070517A2 Pharmaceutical composition and method for treating hypogonadism |
| 06/17/2009 | EP2069503A1 Papaya mosaic virus-based vaccines for influenza |
| 06/17/2009 | EP2069235A2 Method of separating carbon nanotubes |
| 06/17/2009 | EP2068999A2 Implantable devices and methods for treating sinusitis and other disorders |
| 06/17/2009 | EP2068952A2 Hydroxyapatite tissue filler and its preparation and use |
| 06/17/2009 | EP2068940A2 Mri trackable drug delivery particles, uses and methods thereof |
| 06/17/2009 | EP2068937A2 Polymer-stabilized liposomal compositions and methods of use |
| 06/17/2009 | EP2068932A2 Compositions and drug-delivery systems comprising rapamycin analogs and paclitaxel |
| 06/17/2009 | EP2068900A2 Film-delivering rinse |
| 06/17/2009 | EP2068885A1 Vitamin d compositions and method of administration to a human being |
| 06/17/2009 | EP2068876A2 Aqueous formulation comprising an antitumor agent |
| 06/17/2009 | EP2068847A1 Preparation and composition of meloxicam transdermal drug delivery system |
| 06/17/2009 | EP2068845A2 Microencapsules containing surface-modified microparticles and methods of forming and using the same |
| 06/17/2009 | EP2068844A2 Programmable buoyant delivery technology |
| 06/17/2009 | EP2068843A2 Disposable infusion device with automatic unlocking mechanism |
| 06/17/2009 | EP2068842A2 Active ingredient containing stabilised solid medicinal forms and method for the production thereof |
| 06/17/2009 | EP2068841A2 Novel formulations of proton pump inhibitors and methods of using these formulations |
| 06/17/2009 | EP2068840A2 Hydrophobic abuse deterrent delivery system |
| 06/17/2009 | EP2068839A2 Pharmaceutical compositions comprising nilotinib or its salt |
| 06/17/2009 | EP2068838A1 Pharmaceutical formulations comprising clopidogrel |
| 06/17/2009 | EP2068837A2 Granular pharmaceutical compositions |
| 06/17/2009 | EP2068836A2 Dry powder compound formulations and uses thereof |
| 06/17/2009 | EP2068835A2 Imatinib compositions |
| 06/17/2009 | EP2068834A2 Stable powder formulations of aluma-dsorbed vaccines |
| 06/17/2009 | EP2068833A2 Parenteral preparations of gi-safer phospholipid-associated anti-inflammatories and methods of preparation and use |
| 06/17/2009 | EP2068832A2 Liposome complexes containing pharmaceutical agents and methods |
| 06/17/2009 | EP2068831A2 Anti-migraine oral spray formulations and methods |